can you help me find some details about how mutated KRAS affect cancer cells

Certainly! Mutations in the KRAS gene are known to play a significant role in the development and progression of various types of cancer. Here are some details about how mutated KRAS affects cancer cells:

1. Constitutive Activation: Mutations in the KRAS gene lead to a constitutively active form of the KRAS protein, which means that it is always "switched on" and continuously signals downstream pathways, even in the absence of external growth signals. This persistent activation promotes uncontrolled cell growth and division, a hallmark of cancer.

2. Cell Proliferation: Mutated KRAS promotes the proliferation of cancer cells by activating multiple signaling pathways involved in cell cycle progression and cell survival. This leads to increased cell division and decreased cell death, contributing to the rapid growth of tumors.

3. Resistance to Apoptosis: Apoptosis is a programmed cell death mechanism that eliminates damaged or abnormal cells. Mutated KRAS can inhibit apoptosis by interfering with the normal regulation of cell death pathways. This allows cancer cells to survive and accumulate, contributing to tumor formation and growth.

4. Angiogenesis: Mutated KRAS can induce the formation of new blood vessels in a process called angiogenesis. This is important for supplying oxygen and nutrients to cancer cells, enabling their survival and growth even in low-nutrient environments.

5. Metastasis: Mutated KRAS has been associated with increased metastatic potential, allowing cancer cells to invade nearby tissues and spread to distant organs. It promotes the epithelial-mesenchymal transition (EMT), a process that enhances cell migration and invasion capabilities.

6. Resistance to Therapies: Cancer cells with mutated KRAS are often resistant to certain targeted therapies, such as EGFR inhibitors, due to their persistent signaling through alternative pathways. This poses a challenge for treatment and contributes to the poor prognosis associated with KRAS-mutated cancers.

It's important to note that the effects of mutated KRAS can vary depending on the specific cancer type and the other genetic alterations present within the tumor.